Program
CBP-0276
A development code. Also written as “CBP-0276 Acetate”, “CBP-0276 capsules 100mg” and “CBP-0276 200mg BID”.
Its studies are mostly in Arthritis, Psoriatic · Psoriasis, led by Clarent Biopharma.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Clarent Biopharma | 43 open or running | phase 2since Sep 24, 2025 | Sep 8, 2025 | Feb 2027phase 2 · NCT07706530 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 8, 2025First study: phase 1 study in Healthy VolunteersFirst studyNCT07708831 · 64 enrolled · Mexico
- Sep 24, 2025Phase 2 study in PsoriasisNCT07204639 · 100 planned · Mexico
- Jun 25, 2026Phase 2 study in Hip or Knee ReplacementNCT07687966 · 80 planned · Mexico
- Jul 10, 2026Phase 2 study in Arthritis, PsoriaticNCT07706530 · 240 planned · Mexico
Ahead
- Feb 2027Primary completion: phase 2 study in Arthritis, PsoriaticNCT07706530
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07706530Arthritis, Psoriatic · Mexico | 2 | Not yet recruiting | Feb 2027 | 240 |
| NCT07687966Hip or Knee Replacement · Mexico | 2 | Recruiting | Jun 30, 2026 | 80 |
| NCT07204639Psoriasis · Mexico | 2 | Recruiting | Jul 31, 2026 | 100 |
| NCT07708831Healthy Volunteers · Mexico | 1 | Completed | Feb 16, 2026 | 64 |
How it is read
Names in the registry
- “CBP-0276 Acetate”, 1 entry
- “CBP-0276 capsules 100mg”, 1 entry
- “CBP-0276”, 1 entry
- “CBP-0276 200mg BID”, 1 entry
Codes read as this program: CBP0276.
Conditions, from the studies’ own filings
- Arthritis, Psoriatic, 1 study
- Psoriasis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.